期刊文献+

甲状腺髓样癌的组织病理学和免疫组织化学的研究 被引量:5

Histopathologicalandimmunohistochemicalstudiesonmedularythyroidcarcinoma
原文传递
导出
摘要 为探讨甲状腺髓样癌的多分化,用免疫组织化学方法对24例甲状腺髓样癌进行研究。结果显示:癌组织中见甲状腺球蛋白阳性细胞3例、降钙素阳性细胞24例、铬粒素A阳性细胞23例、5-羟色胺阳性细胞14例、神经元特异性烯醇化酶和生长抑素阳性细胞均为10例、血管活性肠肽阳性细胞4例、S-100蛋白阳性细胞1例。本组癌的多种抗原表达提示,它可能来源于可以产生多种激素的神经外胚叶细胞。另有3例见甲状腺球蛋白阳性癌细胞,提示:甲状腺髓样癌伴滤泡上皮分化和混合性髓样癌并不少见,可能来源于能向两个方向分化为滤泡上皮细胞和滤泡旁细胞的后腮干细胞。 Inordertostudythemultidiferentiationofmedularycarcinomaofthethyroidgland(MCT),24casesofMCTwereexaminedforthepresenceofimmunoreactivecalcitonin(CT),thyroglobulin(Tg),chromograninA(CgA),somatostatin(SS),serotonin(5-HT),S-100protein(S-100),neuron-specificenolase(NSE),vasoactiveintestinalpolypeptide(VIP),adrenocorticotrophin(ACTH)andneurofilamentprotein(NF)byusingimmunohistochemicalABCmethods.ResultsshowedthatCT-immunoreactivecelswerepresentinaltumors.Tgwaspresentinthreetumors.23casescontainedCgA-immunoreactivecels.14tumorscontained5-HT-immunoreactivecels,10caseswereimmunoreac-tivetoNSEandSS.4tumorscontainedVIP-immunoreativecelsandonlyonecaseswaspositiveforS-100.Thedemonstrationofimmunoreactivityformultipleantigensin24casessuggeststhattheoriginofmedularythyroidcarcinomamayoriginatefromneuroectodermcelspotentialycapableofproducingnumeroushormonesubstances.Inaddition,astheneoplasticcelsin12%ofthetumorscontaininghor-monesubstancesaswelasthyroglobulin,itissuggestedthatfolicularepithelialdifferentiationandmixedmedularythyroidcarcinomamaybemorecommonthanpreviouslysuspected.Recentstudiesin-dicatethatmixedcarcinomaofthethyroidmaybederivedfromcommonstemcelsinposteriorbranchiacapableofdiferentiatingintobothfolicularandparafoliculartumorcels.
出处 《中华病理学杂志》 CAS CSCD 北大核心 1996年第6期332-335,共4页 Chinese Journal of Pathology
关键词 甲状腺肿瘤 免疫组织化学 组织病理学 ThyroidneoplasmsImmunohistochemistry
  • 相关文献

同被引文献24

  • 1李树玲,杨力珍.甲状腺髓样癌[J].普外临床,1989,4(1):52-55. 被引量:11
  • 2Siggelkow H, Melzer A, Nolte W, et al. Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy [ J ]. Eur J Endocrinol,2001,144(5) :467 - 473.
  • 3Hansford JR, Mulligan LM. Multiple endocrine neoplasia type 2 ( MEN 2) and RET:from neoplasia to neurogenesis[J] .J Med Genet,2000,37(11) :817 - 827.
  • 4Driman D, Murray D, Kovacs K, et al. Encaapsulated medullary carcinoma of the thyroid. A morphologic study including im munocytochemistry,electron microscopoy, flow cytometry. and in situ hybridization[J]. Am J Surg Pathol, 1991,15( 11 ): 1089 - 1095.
  • 5Fuchshuber PR, Loree TR, Hicks WL, et al. Medullary carcinoma of the thyroid: prognostic factors and treatments recommendations [ J ]. Ann Surg Onco,1998,5(1):81 -86.
  • 6Brunt LM,Wells SA. Advances in the diagnosis and treatment of medullary thyroid carcinoma[J]. J Surg Clin North Am,1987,67(2):263-279.
  • 7Hofstra RM,Landsvater RM,Ceccherini I,et al. A mutation in the RET protooncogene associated with MEN2B and sporadic medullary carcinoma[J].Nature 1994;367(6461):375-376.
  • 8Sternberg SS. 诊断外科病理学[M]. 第3版. 回允中译. 北京:北京大学出版社 ,2003.549.
  • 9Saad MF,Fritsche HA Jr,Samaan NA. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid[J]. J Clin Endocrinol Metab,1984,58(5):889-894.
  • 10Engelbach M,Gorges R, Forst T et al.  Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements[J]. J Clin Endocrinol Metab, 2000, 85(5):1890-1894.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部